LIVING WELL PARTNERSHIP — All Prescriptions & Medications — Page 7
Practice Code: J82622 | SOUTHAMPTON, SO19 9GH
Showing results 301-350 of 907
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Neomycin sulfate | 241 | 3,780 | £479 | +306.5% ▲ |
| Ciprofloxacin | 240 | 5,256 | £559 | +501.8% ▲ |
| Fludrocortisone acetate | 240 | 12.0K | £2.2K | +127.5% ▲ |
| Phenytoin sodium | 239 | 18.7K | £3.2K | +195.9% ▲ |
| Canagliflozin | 238 | 10.2K | £12.7K | +65.8% ▲ |
| 232 | 14.5K | £4.2K | +238.7% ▲ | |
| Flupentixol hydrochloride | 230 | 14.1K | £845 | +602.1% ▲ |
| RtS 1.5 - 1.6 kcal/ml milkshake higher protein (0913011) | 229 | 2.1M | £24.3K | +1,123.2% ▲ |
| Dexamethasone | 229 | 9,865 | £5.0K | +283.5% ▲ |
| 229 | 31.5K | £4.6K | +621.1% ▲ | |
| Metronidazole | 228 | 6,617 | £1.8K | +247.0% ▲ |
| Etoricoxib | 228 | 10.1K | £2.1K | +183.0% ▲ |
| Carmellose sodium | 227 | 21.8K | £2.9K | +250.3% ▲ |
| Ranolazine | 226 | 16.7K | £3.0K | +33.0% ▲ |
| Flecainide acetate | 223 | 21.2K | £739 | +185.6% ▲ |
| Naratriptan hydrochloride | 223 | 1,943 | £417 | +752.9% ▲ |
| Domperidone | 221 | 14.3K | £674 | +519.6% ▲ |
| Verapamil hydrochloride | 220 | 21.6K | £1.9K | +142.5% ▲ |
| Combined ethinylestradiol 20mcg | 220 | 13.3K | £3.6K | +321.2% ▲ |
| Aclidinium bromide/formoterol | 218 | 304 | £9.4K | +520.1% ▲ |
| Other individually formulated bought in preparations | 217 | 8,420 | £2.8K | +564.2% ▲ |
| 216 | 28.5K | £54.2K | +343.2% ▲ | |
| Desmopressin acetate | 215 | 17.2K | £13.9K | +312.2% ▲ |
| 214 | 117.9K | £1.0K | +134.7% ▲ | |
| Terbinafine hydrochloride | 213 | 11.5K | £4.6K | +244.6% ▲ |
| 213 | 8,215 | £37.2K | +371.0% ▲ | |
| Ondansetron hydrochloride | 207 | 9,588 | £3.4K | +326.6% ▲ |
| Sodium picosulfate | 206 | 60.9K | £5.4K | +467.6% ▲ |
| Prucalopride | 206 | 6,566 | £3.0K | +429.1% ▲ |
| Urea | 206 | 87.3K | £3.0K | +208.3% ▲ |
| Metronidazole | 205 | 9,165 | £2.7K | +445.5% ▲ |
| Celecoxib | 204 | 16.4K | £831 | +208.9% ▲ |
| Olopatadine | 202 | 1,455 | £1.4K | +360.5% ▲ |
| Rizatriptan | 201 | 2,199 | £7.6K | +238.2% ▲ |
| Mometasone furoate/olopatadine hydrochloride | 201 | 322 | £4.1K | +1,750.2% ▲ |
| Biphasic insulin aspart | 199 | 2,567 | £15.0K | +96.0% ▲ |
| Lidocaine | 198 | 9,435 | £1.6K | +1,622.7% ▲ |
| Theophylline | 196 | 14.2K | £7.2K | +134.4% ▲ |
| 196 | 13.7K | £27.4K | +480.4% ▲ | |
| Goserelin acetate | 192 | 192 | £21.7K | +335.8% ▲ |
| 192 | 12.6K | £3.1K | +893.3% ▲ | |
| Vitamin B compound | 190 | 19.5K | £889 | +36.4% ▲ |
| Valsartan | 189 | 10.9K | £2.6K | +220.9% ▲ |
| Amiodarone hydrochloride | 188 | 7,560 | £410 | +191.5% ▲ |
| Risedronate sodium | 184 | 1,256 | £365 | +51.7% ▲ |
| Anastrozole | 183 | 9,156 | £342 | +101.0% ▲ |
| 182 | 2,183 | £1.2K | +78.2% ▲ | |
| Mometasone/glycopyrronium/indacaterol | 181 | 6,780 | £9.6K | +1,094.0% ▲ |
| Cinnarizine | 179 | 23.8K | £1.2K | +282.5% ▲ |
| Fluorouracil (Sunscreen) | 177 | 7,150 | £5.7K | +386.0% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.